Skip to main content

Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity

Searching for OpenAIRE data...

Publications

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation

Author(s): Guillermo Yoldi, Pasquale Pellegrini, Eva M. Trinidad, Alex Cordero, Jorge Gomez-Miragaya, Jordi Serra-Musach, William C. Dougall, Purificación Muñoz, Miguel-Angel Pujana, Lourdes Planelles, Eva González-Suárez
Published in: Cancer Research, Issue 76/19, 2016, Page(s) 5857-5869, ISSN 0008-5472
DOI: 10.1158/0008-5472.can-15-2745

RANKL inhibitors for osteosarcoma treatment: hope and caution

Author(s): Eva M. Trinidad, Eva González-Suárez
Published in: Annals of Translational Medicine, Issue 4/24, 2016, Page(s) 534-534, ISSN 2305-5839
DOI: 10.21037/atm.2016.12.10

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Author(s): Roger von Moos, Luis Costa, Eva Gonzalez-Suarez, Evangelos Terpos, Daniela Niepel, Jean–Jacques Body
Published in: Cancer Treatment Reviews, 2019, ISSN 0305-7372
DOI: 10.1016/j.ctrv.2019.05.003

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Author(s): Annette T. Byrne, Denis G. Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Andrew V. Biankin, Alejandra Bruna, Eva Budinská, Carlos Caldas, David K. Chang, Robert B. Clarke, Hans Clevers, George Coukos, Virginie Dangles-Marie, S. Gail Eckhardt, Eva Gonzalez-Suarez, Els Hermans, Manuel Hidalgo, Monika A. Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunh
Published in: Nature Reviews Cancer, Issue 17/4, 2017, Page(s) 254-268, ISSN 1474-175X
DOI: 10.1038/nrc.2016.140

European Network of Breast Development and Cancer turned 10 years: a growing family of mammary gland researchers

Author(s): Zuzana Koledova, Beatrice A. Howard, Johanna Englund, Karsten Bach, Mohammed Bentires-Alj, Eva Gonzalez-Suarez
Published in: Breast Cancer Research, Issue 20/1, 2018, ISSN 1465-542X
DOI: 10.1186/s13058-018-1032-9

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

Author(s): Adrián Sanz-Moreno, Sonia Palomeras, Kim Pedersen, Beatriz Morancho, Tomas Pascual, Patricia Galván, Sandra Benítez, Jorge Gomez-Miragaya, Marina Ciscar, Maria Jimenez, Sonia Pernas, Anna Petit, María Teresa Soler-Monsó, Gemma Viñas, Mansour Alsaleem, Emad A. Rakha, Andrew R. Green, Patricia G. Santamaria, Celine Mulder, Simone Lemeer, Joaquin Arribas, Aleix Prat, Teresa Puig, Eva Gonzalez-S
Published in: Breast Cancer Research, Issue 23/1, 2021, ISSN 1465-542X
DOI: 10.1186/s13058-021-01390-2

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Author(s): Clara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, Marina Ciscar, Alexandra Barranco, Enrique Hernández-Jiménez, Marion Maetens, Roberto Salgado, Maria Zafeiroglou, Pasquale Pellegrini, David Venet, Soizic Garaud, Eva M. Trinidad, Sandra Benítez, Peter Vuylsteke, Laura Polastro, Hans Wildiers, Philippe Simon, Geoffrey Lindeman, Denis Larsimont, Gert Van den Eynden, Chloé Velghe, Françoise R
Published in: Nature Communications, Issue 11/1, 2020, ISSN 2041-1723
DOI: 10.1038/s41467-020-20138-8